Showing results (1-10 of 90) with videos related to
Sort By:
Pageof 9
The Pavlovian Journal of Biological Science|January 1, 1979
Conditioning and the classification of the chronic schizophrenic patientT A Ban, J V Ananth, H E LehmannCanadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|March 1, 1997
The history of the psychopharmacology of schizophreniaH E Lehmann, T A BanInternational Pharmacopsychiatry|January 1, 1981
The use of nicotinic acid and pyridoxine in the treatment of schizophreniaW M Petrie, T A Ban, J V AnanthPsychopharmacology Communications|January 1, 1975
Ascorbic acid levels in chronic psychotic patientsP Clement, T A Ban, H E LehmannInternational Pharmacopsychiatry|January 1, 1978
A review of nicotinic acid, N-methylated indoleamines and schizophreniaD Luchins, T A Ban, H E LehmannInternational Pharmacopsychiatry|January 1, 1978
Butaclamol in the treatment of schizophrenia. A standard-controlled clinical trialJ N Nestoros, H E Lehmann, T A BanArchives of Sexual Behavior|October 1, 1981
Sexual behavior of the male schizophrenic: the impact of illness and medicationsJ N Nestoros, H E Lehmann, T A BanInternational Pharmacopsychiatry|January 1, 1975
Psychotherapeutic profile of a new psychoactive drug trazodone (AF-1161)H E Lehmann, T A Ban, G V SchwartzInternational Pharmacopsychiatry|January 1, 1977
Transmethylation hypothesis of schizophrenia: methionine and nicotinic acidJ N Nestoros, T A Ban, H E LehmannInternational Pharmacopsychiatry|January 1, 1977
WIN 27,147-2 in the treatment of depression. An uncontrolled clinical studyJ N Nestoros, T A Ban, H E LehmannPageof 9